Clopidogrel and Epzicom drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopidogrel (clopidogrel) and Epzicom (abacavir sulfate; lamivudine). Common drug interactions include anhedonia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Clopidogrel and Epzicom. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Epzicom?

Epzicom has active ingredients of abacavir sulfate; lamivudine. It is often used in hiv infection. eHealthMe is studying from 4,937 Epzicom users. Check the latest studies of Epzicom.



On Jul, 06, 2026

26 people who take Clopidogrel and Epzicom together, and have interactions are studied.

Clopidogrel and Epzicom drug interactions.

What are the common drug interactions of Clopidogrel and Epzicom, by gender? *:

female:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Chronic kidney disease
  6. Bone loss
  7. Depression
  8. Osteonecrosis (death of bone)
  9. Osteoporosis (bones weak and more likely to break)
  10. Renal impairment (severely reduced kidney function)

male:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Back pain
  4. Blood creatinine increased
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  7. Depression
  8. Dyspnoea (difficult or laboured respiration)
  9. Dysstasia (difficulty in standing)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Clopidogrel and Epzicom, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone loss
  4. Chronic kidney disease
  5. Emotional distress
  6. Osteonecrosis (death of bone)
  7. Pain

40-49:

n/a

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Pain
  6. Renal impairment (severely reduced kidney function)
  7. Bone density decreased
  8. Blood creatinine increased
  9. Insomnia (sleeplessness)
  10. Osteoporosis (bones weak and more likely to break)

60+:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Arthralgia (joint pain)
  4. Blood creatinine increased
  5. Bone density decreased
  6. Bone pain
  7. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  9. Gait disturbance
  10. Neuropathy peripheral (surface nerve damage)

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 5 people, 19.23%
  2. Pain: 4 people, 15.38%
  3. Bacterial Infection: 4 people, 15.38%
  4. Stress And Anxiety: 2 people, 7.69%
  5. Pain In Extremity: 2 people, 7.69%
  6. Muscle Aches (muscle pain): 2 people, 7.69%
  7. High Blood Pressure: 2 people, 7.69%
  8. Fungal Infection: 2 people, 7.69%
  9. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 7.69%
  10. Diabetes: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and Epzicom?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clopidogrel and Epzicom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Epzicom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clopidogrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epzicom and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel and abacavir sulfate; lamivudine (the active ingredients of Clopidogrel and Epzicom, respectively), and Clopidogrel and Epzicom (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: